Business Context and Reporting Period
This Form 8-K was filed by Coherus BioSciences, Inc. on May 10, 2017, reporting a significant legal event. The company is incorporated in Delaware and operates from Redwood City, California.
Key Financial Metrics
This filing does not provide financial data such as revenue, profit, cash flow, margins, debt, or liquidity. The document is a current report focused solely on a specific legal event.
Material Changes
On May 10, 2017, Amgen Inc. and Amgen Manufacturing Limited filed a complaint against Coherus in the United States District Court for the District of Delaware. The complaint alleges that Coherus is infringing one or more claims of Amgen's U.S. Patent No. 8,273,707.
Guidance, Outlook, and Risks
The filing identifies a material legal contingency involving patent infringement litigation. No management commentary, financial guidance, or outlook is provided in this specific report. The primary risk disclosed is the potential outcome of the lawsuit filed by Amgen.
Investor Verification Checklist
- Verify the status and details of the lawsuit filed by Amgen in the U.S. District Court for the District of Delaware.
- Review the specific claims of U.S. Patent No. 8,273,707 to understand the scope of the alleged infringement.
- Assess the potential financial impact of this litigation on Coherus's operations and product portfolio.
- Monitor for future filings regarding Coherus's response to the complaint or settlement negotiations.